Our history
Transcutan was founded in 2001 as a spin-off from research at Uppsala University Hospital and Sahlgrenska University Hospital in Gothenburg. The founders wanted to improve the existing access care by developing a new concept for intracorporal access ports.
After several years of tests and studies, the first product, T-port™ Enteral Access System, received its CE mark and was launched in 2014.
Since 2016 we are distributors for TauroPharm’s unique antimicrobial catheter lock solutions, TauroLock™.